Naval Daver, MD, MBBS

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Essential thrombocythemia→
• Myelodysplastic neoplasm with increased blasts type 2→
• Blastic plasmacytoid dendritic cell neoplasm→
• Langerhans cell histiocytosis→
• Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent→
• Non-Langerhans cell histiocytosis→
• Myelodysplastic neoplasm with increased blasts→
• Myelodysplastic neoplasm with increased blasts type 1→
• Hemophagocytic syndrome→
• Classic hairy cell leukemia→
• Chronic myelomonocytic leukemia→

Clinical trials (9)

• NCT03850574
• NCT02420873
• NCT03259230
• NCT02385110
• NCT02530476
• NCT01893320
• NCT00038610
• NCT01787487
• NCT02225574

Verify independently

• ClinicalTrials.gov PI search for Naval Daver, MD
• NPPES NPI registry entry

Other specialists for Essential thrombocythemia

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Srdan Verstovsek, MD, M.D., PhD
  M.D. Anderson Cancer Center
  TX
• Harinder Gill, MD, MD
  The University of Hong Kong
  CA
• Naveen Pemmaraju, M.D
  M.D. Anderson Cancer Center
  TX
• Gabriela Hobbs, MD, MD
  Massachusetts General Hospital
  MA
• Claire Harrison, Dr
  St Thomas' Hospital
• Anthony R Green, Prof
  Addenbrooke's Hospital and University of Cambridge
• Jorge Cortes, MD
  UT MD Anderson Cancer Center
• Anand A Patel
  City of Hope Comprehensive Cancer Center LAO

See all specialists for Essential thrombocythemia →